CARDINALI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 172
EU - Europa 163
AS - Asia 162
OC - Oceania 2
Totale 499
Nazione #
US - Stati Uniti d'America 171
SG - Singapore 82
IT - Italia 81
HK - Hong Kong 47
IE - Irlanda 38
CN - Cina 18
DE - Germania 13
KR - Corea 12
CZ - Repubblica Ceca 7
FI - Finlandia 6
AT - Austria 3
RO - Romania 3
SE - Svezia 3
UA - Ucraina 3
ES - Italia 2
RU - Federazione Russa 2
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
FR - Francia 1
LT - Lituania 1
NZ - Nuova Zelanda 1
TM - Turkmenistan 1
Totale 499
Città #
Singapore 64
Hong Kong 47
Perugia 44
Dublin 38
Boardman 35
Chandler 33
Santa Clara 18
Seoul 12
Munich 11
San Mateo 10
Medford 6
Altamura 5
Helsinki 5
Lawrence 5
Princeton 5
Andover 4
New York 4
Olomouc 4
Rome 4
Arezzo 3
Brno 3
Florence 3
Guangzhou 3
Redmond 3
Vienna 3
Wilmington 3
Ancona 2
Chiajna 2
Collazzone 2
Gijón 2
San Nicola la Strada 2
San Paolo di Civitate 2
Ashgabat 1
Auckland 1
Baku 1
Beijing 1
Dallas 1
Dhaka 1
Foligno 1
Ivrea 1
Lappeenranta 1
Los Angeles 1
Montréal 1
Moscow 1
Nuremberg 1
Paris 1
Quattro Castella 1
Saint Petersburg 1
Sector 6 1
Shanghai 1
Shijiazhuang 1
Sydney 1
Wuhan 1
Totale 408
Nome #
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 88
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 70
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 57
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 39
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 38
Enasidenib and ivosidenib in AML. 30
Current status and future perspectives in targeted therapy of NPM1-mutated AML 28
One disease, two faces: clonally-related AML and MPDCP with skin involvement 23
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 21
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement 20
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 19
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 17
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase 16
NPM1-mutated AML with starry sky pattern 16
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 14
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 13
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 11
Starry sky pattern predicts RAS pathway activation in NPM1‐mutated acute myeloid leukemia 7
Totale 527
Categoria #
all - tutte 3.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 6 0 0
2020/202111 0 0 0 0 2 1 0 0 8 0 0 0
2021/202264 0 8 1 0 1 1 0 9 3 8 27 6
2022/2023119 5 19 2 5 13 10 12 3 41 2 6 1
2023/2024142 3 4 4 2 0 1 45 0 26 5 14 38
2024/2025184 32 33 12 18 58 31 0 0 0 0 0 0
Totale 527